This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Incyte Corporation. Active years: 2021-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2024
Title: The Innovations of Timothy Martin: A Pioneer in Pharmaceutical Discoveries
Introduction: Timothy Martin, a respected inventor hailing from Hockessin, DE (US), has made significant strides in the field of pharmaceutical research with a total of 4 patents to his name.
Latest Patents:
1. Salts and Crystalline Forms of a PD-1/PD-L1 Inhibitor: Martin's groundbreaking patent focuses on solid and salt forms of the PD-1/PD-L1 inhibitor. These forms play a crucial role in treating various diseases, including infectious diseases and cancer.
2. Process of Preparing a PD-1/PD-L1 Inhibitor: His inventive process revolves around preparing the PD-1/PD-L1 inhibitor and its related synthetic intermediates. This inhibitor proves to be beneficial in combating infectious diseases and cancer.
Career Highlights: Timothy Martin is currently affiliated with Incyte Corporation, a renowned pharmaceutical company known for its innovative approach to drug development.
Collaborations: Throughout his career, Martin has collaborated closely with esteemed colleagues such as Zhongjiang Jia and Jiacheng Zhou. Together, they have contributed to the advancement of pharmaceutical research.
Conclusion: Timothy Martin's contributions to the pharmaceutical industry through his patents and research endeavors have not only propelled scientific advancements but also offered promising solutions for the treatment of various diseases. His dedication to innovation continues to inspire future generations in the field of pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile